Acute symptoms, not rectally administered sucralfate, predict for late radiation proctitis: Longer term follow-up of a phase III trial - Trans-Tasman Radiation Oncology Group

International Journal of Radiation Oncology Biology Physics

Volumn 54, Issue 2, 2002, Pages 442-449

  O'Brien, Peter C ^a   Franklin, C Ian ^b   Poulsen, Michael G ^b   Joseph, David J ^c   Spry, Nigel S ^c   Denham, James W ^a  

^a NEWCASTLE MATER HOSPITAL   (Australia)

^b Queensland Radium Institute   (Australia)

^c SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

Late toxicity; Proctitis; Radiotherapy; Sucralfate

Indexed keywords

PROBABILITY; RADIOGRAPHY; RESEARCH AND DEVELOPMENT MANAGEMENT; TOXICITY; TUMORS;

SELF-ASSESSMENT;

ONCOLOGY;

ENEMA; PLACEBO; SUCRALFATE;

ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROCTITIS; PROSTATE CANCER; QUESTIONNAIRE; RECTUM HEMORRHAGE; SELF EVALUATION; STATISTICAL SIGNIFICANCE;

ANTI-ULCER AGENTS; CONFIDENCE INTERVALS; DOUBLE-BLIND METHOD; ENEMA; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; RADIATION INJURIES; RECTAL DISEASES; RECTUM; SUCRALFATE;

EID: 0036804604     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02931-0     Document Type: Article

References (26)

1. Widmark A., Fransson P., Tavelin B. Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age matched control. Cancer. 74:1994;2520-2532.
2. Crook J., Esche B., Futter N. Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function The patient's perspective . Urology. 47:1996;387-394.
3. Shrader-Bogen C.L., Kjellberg J.L., McPherson C.P., et al. Quality of life and treatment outcomes Prostate carcinoma patients' perspectives after prostatectomy or radiation therapy . Cancer. 79:1997;1977-1986.
4. Pilepich M.V., Asbell S.O., Krall J.M., et al. Correlation of radiotherapeutic parameters and treatment related morbibity - Analysis of RTOG study 77-06. Int J Radiat Oncol Biol Phys. 13:1987;1007-1012.
5. Hanks G.E. External beam radiation therapy for clinically localized prostate cancer Patterns of care studies in the United States . NCI Monogr. 7:1988;75-84.
6. Elsaid A.A., Elassal S. Sucralfate with pelvic radiotherapy Sense or nonsense? Int J Radiat Oncol Biol Phys. 42:(Suppl. 1):1999;283.
7. Henriksson R., Franzén L., Littbrand B. Effects of sucralfate on acute and late bowel discomfort following radiotherapy of pelvic cancer. J Clin Oncol. 10:1992;969-975.
8. Kneebone A., Mameghan H., Bolin T., et al. The effect of oral sucralfate on the acute proctitis associated with prostate radiotherapy A double-blind, randomized trial . Int J Radiat Oncol Biol Phys. 51:2001;628-635.
9. Martenson J.A., Bollinger J.W., Sloan J.A., et al. Sucralfate in the prevention of treatment-induced diarrhea in patients receiving pelvic radiation therapy A North Central Cancer Treatment Group phase III double-blind placebo-controlled trial . J Clin Oncol. 18:2000;1239-1245.
10. O'Brien P.C., Franklin C.I., Dear K.B.G., et al. A phase III double-blind randomised study of rectal sucralfate suspension in the prevention of acute radiation proctitis Trans-Tasman Radiation Oncology Group (TROG) . Radiother Oncol. 45:1997;117-123.
11. Valls A., Pestchen I., Prats C., et al. Multicenter double-blind clinical trial comparing sucralfate vs placebo in the prevention of diarrhea secondary to pelvic irradiation. Med Clin (Barc). 113:1999;681-684.
12. Kochhar R., Patel F., Dhar A., et al. Radiation-induced proctosigmoiditis Prospective, randomized, double-blind controlled trial of oral sulfasalazine plus rectal steroids versus rectal sucralfate . Dig Dis Sci. 36:1991;103-107.
13. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 31:1995;1341-1346.
14. Franklin C.I.V. Acute morbidity of radiation therapy for prostate carcinoma. Australas Radiol. 40:1996;140-145.
15. Zimmermann F.B., Feldmann H.J. Radiation proctitis Clinical and pathological manifestations, therapy and prophylaxis of acute and late injurious effects of radiation on the rectal mucosa . Strahlenther Onkol. 174:1998;85-89.
16. Schultheiss T.E., Lee W.R., Hunt M.A., et al. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 37:1997;3-11.
17. Skwarchuk M.W., Jackson A., Zelefsky M.J., et al. Late rectal toxicity after conformal radiotherapy of prostate cancer (I) Multivariate analysis and dose-response . Int J Radiat Oncol Biol Phys. 47:2000;103-113.
18. Zelefsky M.J., Fuks Z., Hunt M., et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol. 1663:2001;876-881.
19. Denham J.W., O'Brien P.C., Dunstan R.H., et al. Is there more than one late radiation proctitis syndrome? Radiother Oncol. 51:1999;43-53.
20. Followill D.S., Kester D., Travis E.L. Histological changes in mouse colon after single- and split-dose irradiation. Radiat Res. 136:1993;280-288.
21. Denham J. Personal communication. 2002.
22. Hovdenak N., Fajardo L.F., Hauer-Jensen M. Acute radiation proctitis A sequential clinicopathologic study during pelvic radiotherapy . Int J Radiat Oncol Biol Phys. 48:2000;1111-1117.
23. Yeoh E., Sun W.M., Russo A., et al. A retrospective study of the effects of pelvic irradiation for gynecological cancer on anorectal function. Int J Radiat Oncol Biol Phys. 35:1996;1003-1010.
24. Goyal R.K., Hirano I. The enteric nervous system. N Engl J Med. 334:1996;1106-1115.
25. MacNaughton W.K. New insights into the pathogenesis of radiation-induced intestinal dysfunction. Aliment Pharmacol Ther. 14:2000;523-528.
26. Khan A.M., Birk J.W., Anderson J.C., et al. A prospective randomized placebo-controlled double-blinded pilot study of misoprostol rectal suppositories in the prevention of acute and chronic radiation proctitis symptoms in prostate cancer patients. Am J Gastroenterol. 95:2000;1961-1966.